UB

Urmila Bohra

Active Director Director DIN 02458003
DIN 02458003 First appointment Sep 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Urmila Bohra

Data last updated:

Urmila Bohra is a Director at Candid Pharma Private Limited (since 2009). The company operates in Pharma.

DIN 02458003
Primary Designation Director
Industry Pharma
First Appointment 04 Sep 2009
Oldest Company Age 17 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Candid Pharma Private Limited U24239GJ2009PTC057983
Director04 Sep 20092009Active

Board colleagues of Urmila Bohra

NameDINCompanyDesignation
Ashish Bohra01792641Candid Pharma Private LimitedDirector
Neetu Bohra08262118Candid Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Candid Pharma Private Limited
Premium access

Shareholding and investment profile for Urmila Bohra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urmila Bohra

Urmila Bohra currently holds 1 directorship: Candid Pharma Private Limited (Director, since 04 Sep 2009).

Urmila Bohra was first appointed on 04 Sep 2009 as Director at Candid Pharma Private Limited.

The current boards of Urmila Bohra's companies include Ashish Bohra (Candid Pharma Private Limited), Neetu Bohra (Candid Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available